Department of Urology, Peking University Third Hospital, Haidian, Beijing, China.
J Endourol. 2023 Sep;37(9):986-994. doi: 10.1089/end.2023.0038. Epub 2023 Jul 5.
To explore the safety and effectiveness of the Pure Retroperitoneal Laparoscopic Peritoneum Incision Technique (PREP-IT) in laparoscopic radical nephrectomy (LRN) and inferior vena cave (IVC) tumor thrombectomy for right renal-cell carcinoma (RCC) with level Mayo I to III venous tumor thrombus (VTT). From May 2015 to September 2020, 92 patients with right RCC and Mayo I to III VTT were retrospectively reviewed, including 57 patients who underwent retroperitoneal LRN and IVC thrombectomy using PREP-IT, and 35 patients who underwent open surgery. PREP-IT refers to dissecting the retroperitoneum and temporarily placing the right kidney into the abdominal cavity to enlarge the retroperitoneal workspace for a safer and faster IVC operation. Compared with the open surgery group, the PREP-IT group had a larger tumor diameter, while a larger proportion of Mayo I tumor thrombus and smaller maximum tumor thrombus width. Two patients (3.5%) in the PREP-IT group had a history of abdominal surgery. No conversion to open surgery or standard laparoscopic surgery occurred in PREP-IT group. Laparoscopic surgery with PREP-IT was characterized by shorter operative time, less surgical blood loss, shorter postoperative hospital stay, and lower postoperative complication rate. With a 33-month (ranges: 2-86) follow-up time period, the estimated mean overall survival time was 57.2 ± 5.3 and 58.1 ± 71.5 months in the PREP-IT group and open surgery group, respectively. Log-rank test indicated no significant difference between the two groups in terms of overall survival and cancer-specific survival. The PREP-IT is relatively safe and feasible for retroperitoneal LRN with right renal tumor and IVC tumor thrombus, allowing for a large workspace and wide exposure for IVC operations.
探讨 Pure Retroperitoneal Laparoscopic Peritoneum Incision Technique(PREP-IT)在腹腔镜根治性肾切除术(LRN)和下腔静脉(IVC)肿瘤栓子切除术治疗右侧肾细胞癌(RCC)伴 Mayo I 至 III 级静脉肿瘤栓子(VTT)中的安全性和有效性。2015 年 5 月至 2020 年 9 月,回顾性分析了 92 例右侧 RCC 合并 Mayo I 至 III 级 VTT 患者的临床资料,其中 57 例行 PREP-IT 后腹膜入路腹腔镜下肾切除术及 IVC 血栓切除术,35 例行开放手术。PREP-IT 指的是解剖后腹膜,将右肾暂时放入腹腔,扩大后腹膜工作空间,以更安全、更快速地进行 IVC 操作。与开放手术组相比,PREP-IT 组肿瘤直径较大,而 Mayo I 级肿瘤血栓比例较大,最大肿瘤血栓宽度较小。PREP-IT 组有 2 例(3.5%)患者有腹部手术史。PREP-IT 组无中转开放手术或标准腹腔镜手术。采用 PREP-IT 的腹腔镜手术具有手术时间短、手术出血量少、术后住院时间短、术后并发症发生率低等特点。随访 33 个月(范围:2-86),PREP-IT 组和开放手术组的估计平均总生存时间分别为 57.2±5.3 和 58.1±71.5 个月。Log-rank 检验表明两组总生存时间和癌症特异性生存时间无统计学差异。对于右侧肾肿瘤合并 IVC 肿瘤栓子的后腹膜 LRN,PREP-IT 相对安全、可行,可提供较大的工作空间和广泛的 IVC 操作暴露。